Home/Filings/4/0001415889-25-017236
4//SEC Filing

Hrustanovic Gorjan 4

Accession 0001415889-25-017236

CIK 0001750284other

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 5:00 PM ET

Size

6.2 KB

Accession

0001415889-25-017236

Insider Transaction Report

Form 4
Period: 2025-06-11
Transactions
  • Award

    Stock Option (right to buy)

    2025-06-11+24,15024,150 total
    Exercise: $4.08Exp: 2035-06-11Common Stock (24,150 underlying)
Footnotes (2)
  • [F1]The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 11, 2025, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.
  • [F2]The Reporting Person is a member of BVF Partners L.P. ("BVF") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the equity grants to BVF. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.

Issuer

Olema Pharmaceuticals, Inc.

CIK 0001750284

Entity typeother

Related Parties

1
  • filerCIK 0001821194

Filing Metadata

Form type
4
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 5:00 PM ET
Size
6.2 KB